The acute effects of sulpiride on the central dopamine turnover in rats: a quantitative histochemical study. 1981

M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga

UI MeSH Term Description Entries
D008297 Male Males
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D011699 Putamen The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS. Nucleus Putamen,Nucleus Putamens,Putamen, Nucleus,Putamens,Putamens, Nucleus
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002421 Caudate Nucleus Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. Caudatus,Nucleus Caudatus,Caudatus, Nucleus,Nucleus, Caudate
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013469 Sulpiride A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed) Aiglonyl,Arminol,Deponerton,Desisulpid,Digton,Dogmatil,Dolmatil,Eglonyl,Ekilid,Guastil,Lebopride,Meresa,Pontiride,Psicocen,Sulp,Sulperide,Sulpitil,Sulpivert,Sulpor,Synédil,Tepavil,Vertigo-Meresa,neogama,vertigo-neogama,Vertigo Meresa,vertigo neogama

Related Publications

M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
May 1989, Neurochemical research,
M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
January 1995, Neurochemical research,
M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
January 1980, Advances in biochemical psychopharmacology,
M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
January 1996, Progress in neuro-psychopharmacology & biological psychiatry,
M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
January 1988, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
March 1977, Neuroscience letters,
M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
November 1975, Life sciences,
M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
January 1969, Pathologie-biologie,
M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
May 1969, Therapeutique (La Semaine des hopitaux),
M Yoshida, and H Yokoo, and H Kojima, and K Suetake, and S Anraku, and K Inanaga
January 1982, Brain research,
Copied contents to your clipboard!